Show simple item record

dc.contributor.authorMedlinskiene, Kristina*
dc.contributor.authorPetty, Duncan R.*
dc.date.accessioned2018-06-12T15:38:56Z
dc.date.available2018-06-12T15:38:56Z
dc.date.issued2017
dc.identifier.citationMedlinskiene K and Petty D (2017) Oral anticoagulants for stroke prevention in non-valvular AF. Prescriber. 28(9): 37-43.en_US
dc.identifier.urihttp://hdl.handle.net/10454/16145
dc.descriptionyesen_US
dc.description.abstractWarfarin and direct oral anticoagulants (DOACs) have been shown to reduce the risk of stroke in patients with atrial fibrillation, yet many patients are still not being anticoagulated. This article discusses the barriers to the initiation of oral anticoagulants, in particular DOACs, and how these can be overcome.en_US
dc.language.isoenen_US
dc.relation.isreferencedbyhttps://doi.org/10.1002/psb.1611en_US
dc.rights© 2018 Wiley. This is the accepted manuscript version of the article above which has been published in final form at https://doi.org/10.1002/psb.1611. This article may be used for non-commercial purposes in accordance with Wiley Terms and Conditions for Self-Archiving.en
dc.subjectWarfarin
dc.subjectDirect oral anticoagulants (DOACs)
dc.subjectStroke prevention
dc.subjectAtrial fibrillation
dc.subjectBarriers
dc.subjectInitiation
dc.titleOral anticoagulants for stroke prevention in nonvalvular AFen_US
dc.status.refereednoen_US
dc.typeArticleen_US
dc.type.versionAccepted manuscripten_US


Item file(s)

Thumbnail
Name:
NOAC article version submitted ...
Size:
819.1Kb
Format:
PDF
Description:
Main article

This item appears in the following Collection(s)

Show simple item record